ENTITY

SanBio Co Ltd (4592 JP)

27

Analysis

Health Care • Japan

Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.

more

Refresh

Exchange Announcement • 15 Nov 2024 14:30

The Results Of The First Commercial Production Run Of Akuugo [R]

Exchange Announcement • 30 Oct 2024 14:00

Notice Concerning The Grant Of New Patent For Cell Therapy Using Sb623 For Chronic Ischemic Stroke In The United States

Exchange Announcement • 25 Sep 2024 15:00

Notice Concerning Today’S Meeting Of The Pharmaceutical Affairs Council

Exchange Announcement • 18 Sep 2024 14:00

Presentation For Financial Results For The 2nd Quarter Of The Fiscal Year Ending January 31, 2025

Exchange Announcement • 17 Sep 2024 14:00

Notice Concerning Recording Of Non-Operating Income And Deferred Income Taxes

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.3

x